SH2B3 and hematologic disorder: Taken together, these results provide a detailed picture of how the LNK SH2 domain interacts with its ligands and coupled with future studies to determine the full repertoire of LNK-interactors in cells, will allow an understanding of how defects in LNK contribute to myeloproliferative, and other haematological diseases.